Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Neuropsychopharmacology ; 46(3): 579-602, 2021 02.
Article in English | MEDLINE | ID: mdl-32781459

ABSTRACT

Maternal immune activation (MIA) and poor maternal nutritional habits are risk factors for the occurrence of neurodevelopmental disorders (NDD). Human studies show the deleterious impact of prenatal inflammation and low n-3 polyunsaturated fatty acid (PUFA) intake on neurodevelopment with long-lasting consequences on behavior. However, the mechanisms linking maternal nutritional status to MIA are still unclear, despite their relevance to the etiology of NDD. We demonstrate here that low maternal n-3 PUFA intake worsens MIA-induced early gut dysfunction, including modification of gut microbiota composition and higher local inflammatory reactivity. These deficits correlate with alterations of microglia-neuron crosstalk pathways and have long-lasting effects, both at transcriptional and behavioral levels. This work highlights the perinatal period as a critical time window, especially regarding the role of the gut-brain axis in neurodevelopment, elucidating the link between MIA, poor nutritional habits, and NDD.


Subject(s)
Fatty Acids, Omega-3 , Prenatal Exposure Delayed Effects , Animals , Behavior, Animal , Brain , Female , Humans , Inflammation , Microglia , Pregnancy
2.
J Hum Nutr Diet ; 33(3): 439-450, 2020 06.
Article in English | MEDLINE | ID: mdl-31856379

ABSTRACT

BACKGROUND: The present study aimed to assess the effect of a healthy diet, enriched or not with pecan nuts or extra-virgin olive oil, on the lipid profile of patients with stable coronary artery disease (CAD). METHODS: This was a randomised clinical trial conducted for 12 weeks with patients aged between 40 and 80 years with stable CAD for more than 60 days. Individuals were randomised into groups [control group (CG) with 67 patients, pecan nut group (PNG) with 68 patients and olive oil group (OOG) with 69 patients]. The CG was prescribed a healthy diet according to the nutritional guidelines; the PNG was prescribed the same healthy diet plus 30 g day-1 of pecan nuts; and the OOG was prescribed a healthy diet plus 30 mL day-1 of extra-virgin olive oil. RESULTS: In total, 204 subjects were submitted to an intention-to-treat analysis. After adjustment for baseline values and type of statin used, there was no difference regarding low-density lipoprotein (LDL)-cholesterol (primary outcome), high-density lipoprotein (HDL)-cholesterol, LDL-cholesterol/HDL-cholesterol ratio and HDL-cholesterol/triglycerides ratio according to groups. However, the PNG exhibited a significant reduction in non-HDL-cholesterol levels [PNG: 114.9 (31) mg dL-1 ; CG: 127 (33.6) mg dL-1 ; OOG: 126.6 (37.4) mg dL-1 ; P = 0.033] and in the total cholesterol/HDL-cholesterol ratio [PNG: 3.7 (0.7); CG: 4.0 (0.8); OOG: 4.0 (0.8); P = 0.044] compared to the CG and OOG. CONCLUSIONS: Supplementing a healthy diet with 30 g day-1 of pecan nuts for 12 weeks did not improve LDL-cholesterol levels but may improve other lipid profile markers in patients with stable CAD.


Subject(s)
Carya , Coronary Artery Disease/diet therapy , Diet, Healthy/methods , Lipids/blood , Olive Oil/administration & dosage , Adult , Aged , Aged, 80 and over , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Coronary Artery Disease/blood , Dietary Supplements , Female , Humans , Intention to Treat Analysis , Male , Middle Aged , Treatment Outcome , Triglycerides/blood
3.
Eur J Clin Nutr ; 70(1): 10-6, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26059745

ABSTRACT

BACKGROUND/OBJECTIVES: Isolated phytochemicals have been shown to reduce blood pressure; however, combinations of phytochemicals have rarely been tested in humans. We hypothesized that a combination of extracts from grape seed and skin (330 mg), green tea (100 mg), resveratrol (60 mg) and a blend of quercetin, ginkgo biloba and bilberry (60 mg) would reduce blood pressure (BP) in hypertensive subjects. SUBJECTS/METHODS: Eighteen individuals meeting BP requirements (⩾130 mm Hg systolic or ⩾85 mm Hg diastolic) and criteria for metabolic syndrome were enrolled in a double-blinded, placebo-controlled, crossover trial (ClinicalTrials.gov, NCT01106170). The 28-day placebo and supplement arms were separated by a 2-week washout period, and 14 -h daytime ambulatory BP was assessed at baseline and at the end point of each arm. RESULTS: BP was not altered after placebo. After supplement treatment, diastolic pressure was reduced by 4.4 mm Hg (P=0.024, 95% CI, 0.6-8.1), systolic pressure was unchanged and mean arterial pressure trended (P=0.052) toward reduction. Serum angiotensin-converting enzyme activity was similar between placebo and supplement arms, but urinary nitrate and nitrite concentrations were significantly increased (P=0.022) after supplementation. Human aortic endothelial cells treated with metabolites of the polyphenols used in the human supplement trial had a significant increase (P=0.005) in insulin-stimulated eNOS phosphorylation and greater (P<0.001) accumulation of nitrates/nitrites. CONCLUSIONS: Our clinical and in vitro data support the theory that this combination of polyphenols reduced diastolic pressure by potentiating eNOS activation and nitric oxide production. Such supplements may have clinical relevance as stand-alone or adjunct therapy to help reduce BP.


Subject(s)
Blood Pressure/drug effects , Dietary Supplements , Hypertension/drug therapy , Magnoliopsida/chemistry , Phytotherapy , Plant Extracts/therapeutic use , Polyphenols/therapeutic use , Adult , Antihypertensive Agents/isolation & purification , Antihypertensive Agents/pharmacology , Antihypertensive Agents/therapeutic use , Antioxidants/isolation & purification , Antioxidants/pharmacology , Antioxidants/therapeutic use , Cross-Over Studies , Double-Blind Method , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Female , Humans , Hypertension/blood , Male , Metabolic Syndrome/blood , Metabolic Syndrome/drug therapy , Metabolic Syndrome/pathology , Middle Aged , Nitric Oxide/biosynthesis , Nitric Oxide Synthase Type III/blood , Phytochemicals/isolation & purification , Phytochemicals/pharmacology , Phytochemicals/therapeutic use , Plant Extracts/pharmacology , Polyphenols/isolation & purification , Polyphenols/pharmacology , Quercetin/isolation & purification , Quercetin/pharmacology , Quercetin/therapeutic use , Resveratrol , Stilbenes/isolation & purification , Stilbenes/pharmacology , Stilbenes/therapeutic use
4.
Arq. bras. med. vet. zootec ; 65(6): 1694-1698, Dec. 2013. ilus
Article in Portuguese | LILACS | ID: lil-696850

ABSTRACT

Um felino que apresentava massa de grandes dimensões, localizada no lábio superior direito, foi submetido à cirurgia para exérese do aumento de volume mantendo-se margem de tecido sadio. O defeito facial foi reconstituído com um flape cutâneo em padrão axial auricular caudal. A ferida apresentou cicatrização em primeira intenção em sua maior extensão, com adequados resultados cosmético e funcional. A avaliação histopatológica revelou se tratar de fibrossarcoma, o qual não apresentou recidivas locais pelo período mínimo de 21 meses de pós-operatório.


A cat presented for clinical evaluation with a large mass on the superior lip was submitted to surgery to remove the tumor with the conservation of healthy tissue around it. The facial defect was reconstructed with a cutaneous flap in the caudal auricular axial pattern. The wound presented first intention healing on the major extension, with adequate functional and cosmetic results. According to the histopathological findings, it was a fibrosarcoma, which did not show any sign of relapse in the next 21 months after the surgical intervention.


Subject(s)
Animals , Cats , Fibrosarcoma/pathology , Neoplasms , /methods , Skin Diseases , Cats
6.
Acta Neurol Scand ; 120(3): 191-7, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19133864

ABSTRACT

OBJECTIVES: To describe the clinical and epidemiological aspects of post-polio syndrome (PPS) and identify predictors of its severity. MATERIALS AND METHODS: 132 patients with PPS were selected at the Neuromuscular Disease Outpatient Clinic of the Federal University of São Paulo. Descriptive analysis was carried out and predictors of PPS severe forms were investigated using an unconditional logistic regression. RESULTS: The average age at onset was 39.4 years. The most common symptoms were fatigue (87.1%), muscle pain (82.4%) and joint pain (72.0%); 50.4% of the cases were severe. The following were associated with PPS severity: a < or =4-year period of neurological recovery (OR 2.8), permanent damage in two limbs (OR 3.6) and residence at the time of acute polio in a city with more advanced medical assistance (OR 2.5). CONCLUSIONS: Health professionals should carefully evaluate polio survivors for PPS and be aware of the implications of muscle overuse in the neurological recovery period.


Subject(s)
Postpoliomyelitis Syndrome/diagnosis , Postpoliomyelitis Syndrome/epidemiology , Adult , Age of Onset , Brazil/epidemiology , Creatine Kinase/blood , Disability Evaluation , Female , Humans , Male , Middle Aged , Postpoliomyelitis Syndrome/blood , Prognosis , Regression Analysis , Risk Factors , Severity of Illness Index
7.
Ann Nutr Metab ; 53(3-4): 199-204, 2008.
Article in English | MEDLINE | ID: mdl-19039212

ABSTRACT

The aim of this study was to compare basal metabolic rate (BMR) of post-polio syndrome (PPS) patients with healthy individuals and to determine its correlation to body composition. BMR (kcal/day) was determined by indirect calorimetry and body composition by dual energy X-ray absorptiometry. BMR was lower in the PPS patient group than in the control group, although it was similar in both groups when adjusted for body surface area, total body mass (TBM), lean body mass (LBM) and fat-free mass (FFM). PPS patients also showed reduced TBM, LBM and FFM in relation to controls. As muscle energy expenditure while at rest contributes only 20% to the BMR, a proportional reduction in BMR and FFM or LBM could suggest that muscle mass or other factors may interfere more than predicted. It was concluded that the prediction of BMR from the Harris-Benedict equation in PPS patients must be carefully reviewed.


Subject(s)
Basal Metabolism/physiology , Body Composition/physiology , Postpoliomyelitis Syndrome/metabolism , Postpoliomyelitis Syndrome/physiopathology , Absorptiometry, Photon/methods , Adult , Body Mass Index , Calorimetry, Indirect/methods , Case-Control Studies , Humans , Male , Mathematics , Middle Aged , Predictive Value of Tests , Sensitivity and Specificity
8.
Ann N Y Acad Sci ; 977: 65-76, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12480734

ABSTRACT

Abeta peptides are thought to be critical molecules in the pathophysiology of Alzheimer's disease (AD) and are the major protein constituents of senile plaques. In most AD cases, Abeta peptides also form some deposits in the cerebrovasculature, leading to cerebral amyloid angiopathy and hemorrhagic stroke. Regional cerebral hypoperfusion is one of the earlier clinical manifestations in both the sporadic and familial forms of AD. In addition, a variety of vascular risk factors of different etiologies (for instance, diabetes, hypertension, high cholesterol level, atherosclerosis, and smoking) constitute risk factors for AD as well, suggesting that functional vascular abnormalities may contribute to AD pathology. We studied the effect of Abeta on constrictor responses elicited by endothelin-1 in isolated human cerebral arteries collected following rapid autopsies. We report that freshly solubilized Abeta potentiates endothelin-1-induced vasoconstriction in isolated human middle cerebral and basilar arteries. The vasoconstriction elicited by Abeta in these large human cerebral arteries appears to be completely antagonized by NS-398, a selective cyclooxygenase-2 inhibitor, or by SB202190, a specific p38 mitogen-activated protein kinase inhibitor, suggesting that Abeta vasoactivity is mediated via the stimulation of a proinflammatory pathway. In addition, a similar proinflammatory response appears to be mediated by Abeta in isolated human brain microvessels, resulting in an increased production of prostaglandin E(2) and F(2alpha). Using a scanner laser Doppler imager, we show a progressive decline with aging in cortical perfusion level in transgenic APPsw mice (line 2576) compared with age-matched control littermates. The relation between the acute proinflammatory and vasoactive properties of Abeta and the chronic progressive hypoperfusion seen in AD (and transgenic models thereof) is yet to be elucidated.


Subject(s)
Alzheimer Disease/physiopathology , Amyloid beta-Peptides/pharmacology , Amyloid beta-Peptides/physiology , Cerebrovascular Circulation/physiology , Inflammation/physiopathology , Alzheimer Disease/epidemiology , Alzheimer Disease/genetics , Free Radicals/metabolism , Humans , Risk Factors , Vasoconstriction/drug effects , Vasoconstriction/physiology
9.
Arq Bras Cardiol ; 76(5): 379-89, 2001 May.
Article in English | MEDLINE | ID: mdl-11359186

ABSTRACT

OBJECTIVE: To compare circulating plasma levels of immunoinflammatory markers in patients with known de novo coronary artery disease and patients with postangioplasty restenosis. METHODS: Using enzymatic immunoabsorbent assay, we measured plasma levels of soluble interleukin-2 receptosr, tumor necrosis factor alpha, and soluble tumor necrosis alpha receptors I and II in 11 patients with restenosis postcoronary angioplasty (restenosis group), in 10 patients with primary atherosclerosis (de novo group) who were referred for coronary angiography because of stable or unstable angina, and in 9 healthy volunteers (control group). Levels of soluble interleukin-2 receptors were significantly higher in the de novo group compared with that in the restenosis and control groups. Levels were also higher in the restenosis group compared with that in the control group. Plasma levels of tumor necrosis alpha and receptor levels were significantly higher in the de novo group compared to with that in the restenosis and control groups, but levels in the restenosis group were not different from that in the controls. CONCLUSION: Coronary artery disease, either primary or secondary to restenosis, is associated with significant immunoinflammatory activity, which can be assessed by examining the extent of circulating plasma levels of inflammatory markers. Moreover, patients with de novo lesions appear to have increased inflammatory activity compared with patients with restenosis.


Subject(s)
Angioplasty, Balloon , Coronary Artery Disease/blood , Receptors, Interleukin-2/blood , Tumor Necrosis Factor-alpha/analysis , Analysis of Variance , Biomarkers/blood , Case-Control Studies , Coronary Disease/blood , Female , Humans , Male , Recurrence , Statistics, Nonparametric
10.
Arq Neuropsiquiatr ; 58(3A): 720-3, 2000 Sep.
Article in Portuguese | MEDLINE | ID: mdl-10973115

ABSTRACT

Two cases of Lafora's disease with prominent movement disorders portraying rare initial manifestations are reported. In both patients, the first manifestations were cerebellar ataxia, dysartria and startle phenomenon. These symptoms occurred before seizures, myoclonic and progressive dementia, which are more well known as manifestations of Lafora's disease. The diagnosis was confirmed by the identification of PAS positive inclusion bodies in deep skin biopsy samples. Our patients presented an unexpected slow progression of the disease, with longer survival. Lafora's disease should be remembered among diseases causing slowly progressive ataxia associated with epileptic seizures.


Subject(s)
Lafora Disease/complications , Movement Disorders/etiology , Adult , Age of Onset , Biopsy , Female , Humans , Inclusion Bodies/pathology , Lafora Disease/drug therapy , Lafora Disease/pathology , Male , Nuclear Family
14.
Arq Bras Cardiol ; 63(3): 185-9, 1994 Sep.
Article in Portuguese | MEDLINE | ID: mdl-7778989

ABSTRACT

PURPOSE: To identify a possible relationship of the extent of coronary artery disease, with risk factors for coronary artery disease and the retinal arteriolar changes (evaluated by fundoscopic examination). METHODS: We studied 96 patients (66 males), 36 to 72 years of age. All patients were studied by selective cinecoronaryarteriography, fundoscopic examination, as well as evaluated for the common risk factors, cigarette smoking diabetes, dislipidemia, systemic hypertension, age, alcoholism, male sex, family history and obesity. RESULTS: Male (p < 0.001) and smoking (p < 0.01) were the statistically significant associations with the extent of coronary artery disease. No significant relationship with the extent of coronary artery disease was present for the other risk factor nor for changes in retinal arteriolar branches. CONCLUSION: A relationship between extent of coronary artery disease with male sex and a cigarette smoker is occurred. No relationship with other risk factors, nor with retinal arteriolar changes were present.


Subject(s)
Coronary Artery Disease/etiology , Retinal Artery , Adult , Aged , Analysis of Variance , Female , Humans , Hypertriglyceridemia/complications , Male , Middle Aged , Retinal Diseases/etiology , Risk Factors , Sex Factors , Smoking/adverse effects
15.
Arq Bras Cardiol ; 61(1): 49-52, 1993 Jul.
Article in Portuguese | MEDLINE | ID: mdl-8285867

ABSTRACT

A twenty one years old man with obstructive hypertrophic cardiomyopathy with resting gradient and which develops subacute infectious endocarditis and acute mitral regurgitation by valvular apparatus destruction. During the course occurs refractory heart failure and sepsis. The association between these diseases and difficulties in management are analyzed, and literature is reviewed. It is emphasized the high mortality of this condition and indication for surgical referral, as well the necessity for infectious endocarditis prophylaxis in patients with obstruction at rest.


Subject(s)
Cardiomyopathy, Hypertrophic/complications , Endocarditis, Subacute Bacterial/complications , Mitral Valve Insufficiency/complications , Acute Disease , Adult , Cardiomyopathy, Hypertrophic/diagnostic imaging , Cardiomyopathy, Hypertrophic/surgery , Echocardiography , Endocarditis, Subacute Bacterial/diagnostic imaging , Endocarditis, Subacute Bacterial/surgery , Humans , Male , Mitral Valve Insufficiency/diagnostic imaging , Mitral Valve Insufficiency/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...